A phase II clinical trial in China has found that berberine ursodeoxycholate (HTD1801) effectively improved HbA1c levels in ...

In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...

A recent clinical trial has found that a plant-based pill could offer a promising new treatment option for people with type 2 ...

Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

Are you ignoring the early signs of kidney disease in diabetes? As diabetic kidney disease is on the rise, here’s what ...

People with Type 2 diabetes are more likely to suffer from heart attacks, strokes, and early death due to a condition called ...

Berberine ursodeoxycholate, a novel gut-liver metabolic modulator, reduces A1c levels and improves glycemic, cardiometabolic, ...

"Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high cholesterol, ongoing studies have shown they can reduce the risk of vision loss in ...

GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to ...

The price of empagliflozin, a commonly prescribed diabetes drug, has been slashed by a staggering 90% in India. This ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...